← Evidence map

ReviewCurrent drug targets2015

IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression.

Daniel A Giles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

61 papers cite itlatest 60 shown

2015
…
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26028039